RuiYi joins with Genor to develop cancer treatment

20-05-2013

San Diego-Shanghai biotechnology startup RuiYi Inc has entered into an exclusive license and collaborative development agreement with Shanghai-based Genor BioPharma to develop the RYI-008 molecule in China.


RuiYi, Genor, RYI-008, cancer

LSIPR